Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Attention Deficit Hyperactivity Disorder Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for attention deficit hyperactivity disorder has seen significant growth in the past few years. The market is projected to increase from a value of $16.29 billion in 2024, reaching $17.38 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%. This robust growth during the historical period is due to an increased occurrence of ADHD, a rise in ADHD cases among children, heightened awareness of ADHD, escalated health care spending, and government efforts to raise mental health awareness.
The market size for attention deficit hyperactivity disorder is poised to witness robust expansion in the coming years, reaching an estimated value of $22.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period can be credited to the rising number of pediatric as well as adult patients receiving treatment, a more sophisticated healthcare infrastructure, the surge in personalized medicine adoption, increased acknowledgement of mental health issues, and a growing trend of utilizing additives and preservatives in children’s nutrition. Observable trends for the forecast span encompass enhancements in technology leading to innovative therapies, progress in diagnostic and treatment methodologies, the introduction of new therapeutic agents, a move towards non-stimulant medications, and progress made in pharmaceutical therapies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21108&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Attention Deficit Hyperactivity Disorder Market?
The surge in the use of personalized medicine is anticipated to spur the development of the attention deficit hyperactivity disorder (ADHD) market in the future. Personalized medicine, a treatment approach that takes into account one’s genetic, environmental, and lifestyle factors for accurate and effective healthcare, is increasingly adopted due to advancements in genomic technologies. These developments allow for treatment adjustments based on a person’s genetic make-up, leading to more efficient and focused therapies. Attention deficit hyperactivity disorder (ADHD) plays an integral role in personalized healthcare by supporting tailored treatment plans that take into account the distinct genetic, environmental, and behavioral attributes of an individual. This leads to more powerful and targeted intervention methods. For example, a report released by the Personalized Medicine Coalition (PMC), a non-profit organization in the U.S., revealed that personalized medicines made up more than one-third of new FDA drug approvals for the fourth year in a row in February 2024. The FDA approved 16 new personalized treatments for rare diseases (up from 6 in 2022), along with 7 cancer drugs, and 3 for other conditions. Consequently, the ongoing rise in personalized medicine adoption is stimulating the ADHD market’s expansion.
Which Key Market Segments Comprise the Attention Deficit Hyperactivity Disorder Market and Drive Its Revenue Growth?
The attention deficit hyperactivity disordermarket covered in this report is segmented –
1) By Type: Stimulants; Non-Stimulants
2) By Age Group: Children; Adults
3) By Gender: Male; Female
4) By Dosage Form: Tablets; Capsules; Other Dosage Forms
5) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Online Pharmacy
Subsegments:
1) By Stimulants: Methylphenidate-based Medications; Amphetamine-based Medications; Mixed Amphetamine Salts; Dexmethylphenidate
2) By Non-Stimulants: Atomoxetine (Strattera); Guanfacine (Intuniv); Clonidine (Kapvay); Bupropion (Wellbutrin)
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21108&type=smp
Which Areas Are Leading Regions in the Attention Deficit Hyperactivity Disorder Market Expansion Across the Globe?
North America was the largest region in the attention deficit hyperactivity disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the attention deficit hyperactivity disorder market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theAttention Deficit Hyperactivity Disorder Market Over the Coming Years?
Major firms in the ADHD market are prioritizing the development of novel medications such as extended-release tablets to enhance the effectiveness of treatment, boost patient compliance, and ensure sustained control of symptoms. Extended-release tablets are engineered to gradually dispense medication over time, thereby guaranteeing constant control of symptoms throughout the day with just a single dose. This not only reduces the need for multiple doses but also increases convenience and adherence to treatment regimens for those with ADHD. For example, in February 2022, Guanfacine XR, a generic version of Takeda Canada Inc.’s INTUNIV XR, was launched by JAMP Pharma Group, a pharmaceutical firm based in Canada. This drug, meant for treating ADHD, is a prolonged-acting form of guanfacine, acting on specific receptors in the brain to enhance attention span, impulse control, and hyperactivity. Available in a range of strengths (1 mg, 2 mg, 3 mg, and 4 mg) and packaged in 100-count bottles, it offers flexibility in treatment.
View the full report here:
How Is the Attention Deficit Hyperactivity Disorder Market Conceptually Defined?
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental condition characterized by persistent inattention, hyperactivity, and impulsivity that interfere with daily functioning. It begins in childhood and can continue into adulthood, affecting focus, self-control, and organization. Treatment may include behavioral therapy, medication, and lifestyle adjustments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21108
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
